Markets:

Overview

News

Currencies

International

Treasuries

KalVista Pharmaceuticals, Inc. - Common Stock (NQ:KALV)

14.91 -0.21 (-1.39%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about KalVista Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 Next >

What's Going With Hereditary Angioedema-Focused KalVista Pharmaceuticals Stock On Tuesday? ↗

February 13, 2024

Results from KalVista Pharmaceuticals' Phase 3 KONFIDENT trial. Sebetralstat, an oral on-demand therapy, shows efficacy for hereditary angioedema.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 13, 2024

Via Benzinga

Insiders Buying Monro And 3 Other Stocks ↗

February 09, 2024

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

Via Benzinga

$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying ↗

February 02, 2024

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

Via Benzinga

Over $1M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

January 30, 2024

Although U.S. stocks closed higher on Monday, there were a few notable insider trades.

Via Benzinga

Insiders Buying Dorian LPG And 2 Other Stocks ↗

January 17, 2024

Although U.S. stocks closed lower on Tuesday, there were a few notable insider trades.

Via Benzinga

KalVista Pharma: Q2 Earnings Insights ↗

December 07, 2023

Via Benzinga

Recap: KalVista Pharma Q4 Earnings ↗

July 07, 2023

Via Benzinga

Analyst Expectations for KalVista Pharma's Future ↗

April 21, 2023

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

January 22, 2024

Via Benzinga

$230M Bet On Talos Energy? Check Out These 4 Stocks Insiders Are Buying ↗

January 22, 2024

Although U.S. stocks closed higher on Friday, there were a few notable insider trades.

Via Benzinga

Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks ↗

January 11, 2024

Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.

Via Benzinga

$6.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

January 08, 2024

Although U.S. stocks closed slightly higher on Friday, there were a few notable insider trades.

Via Benzinga

Around $2.4M Bet On HighPeak Energy? Check Out These 4 Stocks Insiders Are Buying ↗

January 02, 2024

Although U.S. stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 19, 2022

On Wednesday, 200 companies hit new 52-week lows.

Via Benzinga

Expert Ratings for KalVista Pharma ↗

October 05, 2022

KalVista Pharma (NASDAQ:KALV) has observed the following analyst ratings within the last quarter:

Via Benzinga

Where KalVista Pharma Stands With Analysts ↗

October 05, 2022

Analysts have provided the following ratings for KalVista Pharma (NASDAQ:KALV) within the last quarter:

Via Benzinga

KALV Stock Earnings: KalVista Pharma Misses EPS for Q2 2024 ↗

December 07, 2023

KALV stock results show that KalVista Pharma missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

3 Micro-Cap Stocks That Could Be Moonshots ↗

November 14, 2023

If you are hungry for high-risk returns, then these micro-cap stocks to buy could be your winning ticket to future yields.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 27, 2023

Via Benzinga

Gold Rises Over 1%; Elys Game Technology Shares Spike Higher ↗

December 27, 2022

U.S. stocks traded mixed toward the end of trading, with the Dow Jones trading slightly higher on Tuesday.

Via Benzinga

Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session ↗

December 27, 2022

Gainers Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

December 27, 2022

Via Benzinga

Major Indexes Falter As Rocky Year Wraps Up ↗

December 27, 2022

Stocks are struggling to build on their morning gains as investors began to waver on the possibility of a

Via Talk Markets

Dow Rises 100 Points; Crude Oil Rises Over 1% ↗

December 27, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 100 points on Tuesday.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

December 27, 2022

Via Benzinga

Tesla To $370? Plus HC Wainwright Slashes PT On This Stock By 67% ↗

October 06, 2022

HC Wainwright & Co. cut KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) price target from $48 to $16. KalVista Pharmaceuticals shares fell 1.8% to $5.06 in pre-market trading.

Via Benzinga

Why KalVista Pharmaceuticals Shares Are Trading Lower By 59%; Here Are 89 Biggest Movers From Yesterday ↗

October 05, 2022

Losers

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

October 05, 2022

Wednesday saw 127 companies set new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

KalVista Pharmaceuticals, Inc. - Common Stock (NQ:KALV)

Headline News about KalVista Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today